PRESS RELEASE published on 02/25/2025 at 06:30, 1 year 8 months ago Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE® Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE®. Approval for treating retinal diseases granted by UK's MHRA Regulatory Approval UK Biosimilar Formycon AHZANTIVE
PRESS RELEASE published on 02/25/2025 at 05:26, 1 year 8 months ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3Y Change of Director's Interest Notice Dexus Finance Pty Limited announces Change of Director's Interest Notice for Rhoda Phillippo. Appendix 3Y form filed to ASX for public disclosure Real Estate Dexus Finance Pty Limited ASX Release Appendix 3Y Change Of Director's Interest Notice
PRESS RELEASE published on 02/25/2025 at 02:20, 1 year 8 months ago UniDoc - Announces Filing of Amended and Restated Interim Management Discussion and Analysis UniDoc Health Corp. issues amended and restated management's discussion and analysis for clarifying disclosure following continuous disclosure review by the British Columbia Securities Commission British Columbia Securities Commission Management's Discussion And Analysis UniDoc Health Corp. Amended Clarifying Disclosure
PRESS RELEASE published on 02/25/2025 at 00:05, 1 year 8 months ago BluSky Carbon Announces Closing of Convertible Debenture Financing and Unit Offering BluSky Carbon Inc. closes non-brokered private placement of convertible debentures and completes Unit Offering, raising funds for business development Private Placement Business Development Convertible Debentures BluSky Carbon Inc. Unit Offering
PRESS RELEASE published on 02/25/2025 at 00:00, 1 year 8 months ago Onco-Innovations' PKNP Technology Shown in Study to Demonstrate Low Toxicity and High Safety Profile Onco-Innovations Limited announces successful preclinical study results of its second-generation nanoparticle formulation of PNKP Compound, showing enhanced inhibitor delivery with minimal toxicity for potential cancer therapy Preclinical Study Cancer Therapy Onco-Innovations Limited Nanoparticle Formulation PNKP Compound
PRESS RELEASE published on 02/24/2025 at 22:15, 1 year 8 months ago Kingstone Announces Record Operating Profit and Growth for Fourth Quarter and Full Year 2024 Kingstone Companies, Inc. schedules conference call on March 14 for fourth quarter 2024 financial results. Company's preliminary financial performance highlights significant improvements in direct written premiums and operating income Financial Results Conference Call Kingstone Companies Inc. Preliminary Performance Direct Written Premiums
PRESS RELEASE published on 02/24/2025 at 21:27, 1 year 8 months ago Sanofi : Déclaration des transactions sur actions propres
PRESS RELEASE published on 02/24/2025 at 21:27, 1 year 8 months ago Sanofi: Disclosure of trading in own shares
PRESS RELEASE published on 02/24/2025 at 21:15, 1 year 8 months ago Shelly achieves a successful financial year 2024 with profitable growth well above the industry average Shelly Group SE achieves successful financial year 2024 with remarkable growth exceeding industry average, driven by revenue increase and international expansion Revenue Increase Financial Year 2024 Profitable Growth International Expansion Shelly Group SE
PRESS RELEASE published on 02/24/2025 at 21:14, 1 year 8 months ago Inside Information / Other news releases Pernod Ricard successfully completes €800 million bond issuance with a coupon of 3.25% for general corporate purposes, led by Bank of America and others Bond Issuance Bank Of America PERNOD RICARD €800 Million Coupon 3.25%
Published on 11/06/2026 at 22:15, 1 day ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 1 day 10 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 1 day 10 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 1 day 10 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/07/2026 at 13:35, 9 hours 35 minutes ago Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 1 day 2 hours ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 1 day 2 hours ago L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:15, 1 day 3 hours ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 1 day 4 hours ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 19:06, 1 day 4 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 1 day 4 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 1 day 4 hours ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 1 day 4 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL